1092 The CD8+ T cell selectivity of AB248 is essential for optimal anti-tumor activity and safety in nonclinical models

• DOI: 10.1136/jitc-2022-sitc2022.1092
• Publication Date: 2022-11-08T01:17:30Z
• Authors: Kelly Moynihan; Danielle Pappas; Hussein Sultan; Terrence Park; Manu Kumar; Ruth Lan; Irene Ni; Jessie Chen; Michael Chin; Ton Schumacher; Andy Yeung; Robert Schreiber; Ivana Djuretic
• Keywords: 0301 basic medicine; 03 medical and health sciences; 0302 clinical medicine